Table 1 Characteristics of the respondents
From: Physicians’ beliefs and attitudes about Benzodiazepines: a cross-sectional study
Family physicians (n = 184) | Other medical specialists (n = 145) | p-value | Total (n = 329) | |
|---|---|---|---|---|
Gender, n (%) | ||||
Female | 116 (63.0%) | 74 (51.0%) | 0.03a) | 152 (57.7%) |
Male | 68 (37.0%) | 71 (49.0%) | 207 (42.3%) | |
Age group, n (%)* | ||||
≤ 35 years | 101 (55.2%) | 50 (34.5%) | < 0.001a) | 159 (44.4%) |
36–55 years | 27 (14.8%) | 43 (29.7%) | 81 (22.6%) | |
≥ 56 years | 55 (30.1%) | 52 (35.9%) | 118 (33.0%) | |
Age, mean ± sd* | 41.5 ± 14.3 | 46.7 ± 15.9 | 0.002b) | 44.1 ± 15.2 |
Years of clinical practice, mean ± sd | 16.2 ± 14.1 | 22.0 ± 15.5 | < 0.001b) | 19.0 ± 15.0 |
Nr of patient with prescribed BZD for the first time (last 3 months) | ||||
No patients | 31 (16.8%) | 41 (28.3%) | < 0.001a) | 76 (21.2%) |
Between 1 and 5 patients | 121 (65.8%) | 55 (37.9%) | 192 (53.5%) | |
Between 6 and 10 patients | 20 (10.9%) | 17 (11.7%) | 39 (10.9%) | |
More than 10 patients | 5 (2.7%) | 16 (11.0%) | 25 (7.0%) | |
Not applicable | 7 (3.8%) | 16 (11.0%) | 27 (7.5%) | |